Development and Optimization of Novel Emulgel Loaded with Andrographolide-Rich Extract and Sesame Oil Using Quality by Design Approach: In Silico and In Vitro Cytotoxic Evaluation against A431 Cells

An epidermoid carcinoma is a form of non-melanoma skin cancer that originates from the outer layer of the skin’s squamous cells. Previous studies have shown that andrographis extract and andrographolide inhibit the growth and proliferation of epidermoid carcinoma cells while also inducing cell cycle...

Full description

Bibliographic Details
Main Authors: N. V. L. Sirisha Mulukuri, Moumita Dhara, Dheeraj Gupta, Kusum Devi, Pankaj Kumar
Format: Article
Language:English
Published: MDPI AG 2023-06-01
Series:Gels
Subjects:
Online Access:https://www.mdpi.com/2310-2861/9/7/507
_version_ 1797589195640799232
author N. V. L. Sirisha Mulukuri
Moumita Dhara
Dheeraj Gupta
Kusum Devi
Pankaj Kumar
author_facet N. V. L. Sirisha Mulukuri
Moumita Dhara
Dheeraj Gupta
Kusum Devi
Pankaj Kumar
author_sort N. V. L. Sirisha Mulukuri
collection DOAJ
description An epidermoid carcinoma is a form of non-melanoma skin cancer that originates from the outer layer of the skin’s squamous cells. Previous studies have shown that andrographis extract and andrographolide inhibit the growth and proliferation of epidermoid carcinoma cells while also inducing cell cycle arrest and apoptosis. The objective of this study was to improve the anticancer efficacy of the andrographolide-rich extract by delivering it in the form of nanoemulgel. During the formulation of emulgels, sonication, and homogenization were employed, and a 2<sup>2</sup>-factorial design was used to optimize the formulations through the quality by design (QbD) approach. The optimized formulation (AEE8) was subjected to preliminary evaluations along with particle size, drug release, and scanning electron microscopy (SEM) studies. The potential of the optimized emulgel against A431 cell lines was also investigated using MTT assay followed by flow cytometric analysis. The SEM results reveal that the optimized emulgel had a well-defined spherical shape, with a droplet size of 226 ± 1.8 nm, a negative surface charge of −30.1 ± 1.6 mV, and a PDI of 0.157. The cellular data indicate that AEE8 reduced the viability of the A431 cells with an IC<sub>50</sub> of 16.56 μg/mL, as determined by MTT assay when compared to cells treated with the extract alone. Furthermore, the flow cytometric analysis of the optimized emulgel formulation demonstrated a marked G2/M phase arrest. This finding further supports the effectiveness of the gel in disrupting the cell cycle at the critical G2 and M phases, which are pivotal for cell division and proliferation. This disruption in cell cycle progression can impede the growth and spread of cancer cells, making the gel a promising candidate for anti-skin-cancer therapy. The safety of emulgels (AEE8) was validated through rigorous biocompatibility testing conducted on HDF (human dermal fibroblast) cell lines, ensuring their suitability for use. Considering the potential of the nanoemulgel, particularly AEE8, as demonstrated by its favorable properties and its ability to disrupt the cell cycle, it holds great promise as an innovative approach to treating skin cancer.
first_indexed 2024-03-11T01:03:59Z
format Article
id doaj.art-b6c4ee86a27642eea6450dd193bf37d1
institution Directory Open Access Journal
issn 2310-2861
language English
last_indexed 2024-03-11T01:03:59Z
publishDate 2023-06-01
publisher MDPI AG
record_format Article
series Gels
spelling doaj.art-b6c4ee86a27642eea6450dd193bf37d12023-11-18T19:27:04ZengMDPI AGGels2310-28612023-06-019750710.3390/gels9070507Development and Optimization of Novel Emulgel Loaded with Andrographolide-Rich Extract and Sesame Oil Using Quality by Design Approach: In Silico and In Vitro Cytotoxic Evaluation against A431 CellsN. V. L. Sirisha Mulukuri0Moumita Dhara1Dheeraj Gupta2Kusum Devi3Pankaj Kumar4Department of Pharmaceutical Chemistry, NGSM Institute of Pharmaceutical Sciences (NGSMIPS), Nitte (Deemed to be University), Mangalore 575018, IndiaNitte College of Pharmaceutical Sciences, Bangalore 560064, IndiaDepartment of Pharmaceutical Chemistry, NGSM Institute of Pharmaceutical Sciences (NGSMIPS), Nitte (Deemed to be University), Mangalore 575018, IndiaNitte College of Pharmaceutical Sciences, Bangalore 560064, IndiaDepartment of Pharmaceutical Chemistry, NGSM Institute of Pharmaceutical Sciences (NGSMIPS), Nitte (Deemed to be University), Mangalore 575018, IndiaAn epidermoid carcinoma is a form of non-melanoma skin cancer that originates from the outer layer of the skin’s squamous cells. Previous studies have shown that andrographis extract and andrographolide inhibit the growth and proliferation of epidermoid carcinoma cells while also inducing cell cycle arrest and apoptosis. The objective of this study was to improve the anticancer efficacy of the andrographolide-rich extract by delivering it in the form of nanoemulgel. During the formulation of emulgels, sonication, and homogenization were employed, and a 2<sup>2</sup>-factorial design was used to optimize the formulations through the quality by design (QbD) approach. The optimized formulation (AEE8) was subjected to preliminary evaluations along with particle size, drug release, and scanning electron microscopy (SEM) studies. The potential of the optimized emulgel against A431 cell lines was also investigated using MTT assay followed by flow cytometric analysis. The SEM results reveal that the optimized emulgel had a well-defined spherical shape, with a droplet size of 226 ± 1.8 nm, a negative surface charge of −30.1 ± 1.6 mV, and a PDI of 0.157. The cellular data indicate that AEE8 reduced the viability of the A431 cells with an IC<sub>50</sub> of 16.56 μg/mL, as determined by MTT assay when compared to cells treated with the extract alone. Furthermore, the flow cytometric analysis of the optimized emulgel formulation demonstrated a marked G2/M phase arrest. This finding further supports the effectiveness of the gel in disrupting the cell cycle at the critical G2 and M phases, which are pivotal for cell division and proliferation. This disruption in cell cycle progression can impede the growth and spread of cancer cells, making the gel a promising candidate for anti-skin-cancer therapy. The safety of emulgels (AEE8) was validated through rigorous biocompatibility testing conducted on HDF (human dermal fibroblast) cell lines, ensuring their suitability for use. Considering the potential of the nanoemulgel, particularly AEE8, as demonstrated by its favorable properties and its ability to disrupt the cell cycle, it holds great promise as an innovative approach to treating skin cancer.https://www.mdpi.com/2310-2861/9/7/507<i>Andrographis paniculata</i>anticanceremulgelsnon-melanomatopical
spellingShingle N. V. L. Sirisha Mulukuri
Moumita Dhara
Dheeraj Gupta
Kusum Devi
Pankaj Kumar
Development and Optimization of Novel Emulgel Loaded with Andrographolide-Rich Extract and Sesame Oil Using Quality by Design Approach: In Silico and In Vitro Cytotoxic Evaluation against A431 Cells
Gels
<i>Andrographis paniculata</i>
anticancer
emulgels
non-melanoma
topical
title Development and Optimization of Novel Emulgel Loaded with Andrographolide-Rich Extract and Sesame Oil Using Quality by Design Approach: In Silico and In Vitro Cytotoxic Evaluation against A431 Cells
title_full Development and Optimization of Novel Emulgel Loaded with Andrographolide-Rich Extract and Sesame Oil Using Quality by Design Approach: In Silico and In Vitro Cytotoxic Evaluation against A431 Cells
title_fullStr Development and Optimization of Novel Emulgel Loaded with Andrographolide-Rich Extract and Sesame Oil Using Quality by Design Approach: In Silico and In Vitro Cytotoxic Evaluation against A431 Cells
title_full_unstemmed Development and Optimization of Novel Emulgel Loaded with Andrographolide-Rich Extract and Sesame Oil Using Quality by Design Approach: In Silico and In Vitro Cytotoxic Evaluation against A431 Cells
title_short Development and Optimization of Novel Emulgel Loaded with Andrographolide-Rich Extract and Sesame Oil Using Quality by Design Approach: In Silico and In Vitro Cytotoxic Evaluation against A431 Cells
title_sort development and optimization of novel emulgel loaded with andrographolide rich extract and sesame oil using quality by design approach in silico and in vitro cytotoxic evaluation against a431 cells
topic <i>Andrographis paniculata</i>
anticancer
emulgels
non-melanoma
topical
url https://www.mdpi.com/2310-2861/9/7/507
work_keys_str_mv AT nvlsirishamulukuri developmentandoptimizationofnovelemulgelloadedwithandrographoliderichextractandsesameoilusingqualitybydesignapproachinsilicoandinvitrocytotoxicevaluationagainsta431cells
AT moumitadhara developmentandoptimizationofnovelemulgelloadedwithandrographoliderichextractandsesameoilusingqualitybydesignapproachinsilicoandinvitrocytotoxicevaluationagainsta431cells
AT dheerajgupta developmentandoptimizationofnovelemulgelloadedwithandrographoliderichextractandsesameoilusingqualitybydesignapproachinsilicoandinvitrocytotoxicevaluationagainsta431cells
AT kusumdevi developmentandoptimizationofnovelemulgelloadedwithandrographoliderichextractandsesameoilusingqualitybydesignapproachinsilicoandinvitrocytotoxicevaluationagainsta431cells
AT pankajkumar developmentandoptimizationofnovelemulgelloadedwithandrographoliderichextractandsesameoilusingqualitybydesignapproachinsilicoandinvitrocytotoxicevaluationagainsta431cells